GAF Healthcare

Best Medical Oncologists for Targeted Therapy in Hyderabad, India

This page lists 6 targeted therapy doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 6 targeted therapy doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Targeted Therapy doctors in Hyderabad, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Targeted Therapy doctors

Image not available Featured

Dr. Naidu N. Bethune

MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Hi-Tech City Hyderabad, India21+ Years experience
Why consider this doctor?
  • 21+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
  • Consultant — Medical Oncology, American Oncology Institute, Hyderabad
Expertise & Procedures
  • Chemotherapy Administration for Solid and Hematological Cancers
  • Targeted Therapy and Molecular Cancer Treatment
  • Cancer Immunotherapy and Checkpoint Inhibitors
  • Stem Cell Transplantation
  • Bone Marrow Transplantation
View all procedures →
Medical Oncologist Experience: 21+ YearsHospital Affiliation: Yashoda Hospitals, Hi-Tech CityHospital accreditation: NABH, NABL
View Profile Book a Consultation
Image not available

Dr. Nikhil Suresh Ghadyalpatil

MBBS, MD, DM, MNAMS, DNB
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India18+ Years experience
Why consider this doctor?
  • 18+ years of experience in Medical Oncologist
  • Senior Consultant, Medical Oncology, Apollo Hospital, Jubilee Hills, Hyderabad — Present
  • Specialist in hemato-oncology and translational cancer research across leading Indian oncology centres
Expertise & Procedures
  • Chemotherapy Administration for Solid Tumours
  • Immunotherapy and Immune Checkpoint Inhibitor Therapy
  • Molecular Targeted Therapy Planning
  • Hormone Therapy for Breast and Prostate Cancer
  • Adjuvant Chemotherapy Management
View all procedures →
Medical Oncologist Experience: 18+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
View Profile Book a Consultation
Image not available

Dr. Rekha Bansal

MBBS, DNB, DNB (Medical Oncology), DM (Medical Oncology)
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India8+ Years experience
Why consider this doctor?
  • 8+ years of experience in Medical Oncologist
  • Consultant, Medical Oncology — Apollo Hospital, Jubilee Hills, Hyderabad (Present)
  • Over 8 years of clinical experience in oncology and cancer management across tertiary care settings
Expertise & Procedures
  • Adjuvant Chemotherapy for Solid Tumors
  • Neoadjuvant Chemotherapy Planning
  • Palliative Chemotherapy Management
  • Immunotherapy with Checkpoint Inhibitors
  • Molecular Targeted Therapy
View all procedures →
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
View Profile Book a Consultation
Image not available

Dr. Sudha Sinha

MBBS, American Board Certification in Internal Medicine, American Board Certification in Hematology, American Board Certification in Medical Oncology, ECFMG Certification
Clinical Director, HOD & Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospital Hyderabad, India23+ Years experience
Why consider this doctor?
  • 23+ years of experience in Medical Oncologist
  • Clinical Director, HOD, and Senior Consultant in Medical Oncology — Yashoda Hospital, Hyderabad, India (Present)
  • Consultant Medical Oncologist — Care Hospitals, Hyderabad, India
Expertise & Procedures
  • Chemotherapy Administration and Management
  • CAR-T Cell Therapy
  • Cancer Immunotherapy
  • Targeted Therapy for Solid Tumors
  • Hormone Therapy for Breast Cancer
View all procedures →
Medical Oncologist Experience: 23+ YearsHospital Affiliation: Yashoda Hospital
View Profile Book a Consultation
Image not available

Dr. Sumanth Kumar Mallupattu

DM, MD, MBBS
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
CARE Hospitals Hyderabad, India14+ Years experience
Why consider this doctor?
  • 14+ years of experience in Medical Oncologist
  • Senior Consultant, Medical Oncology — CARE Hospitals, Hyderabad
  • Consultant, Haemato-Oncology — Yashoda Hospital, Secunderabad
Expertise & Procedures
  • Chemotherapy for Solid Organ Cancers
  • Cancer Immunotherapy (ICIs and CAR-T)
  • Targeted Therapy and Molecular-Guided Treatment
  • Hormone Therapy for Breast Cancer
  • Management of Lymphomas and Leukaemias
View all procedures →
Medical Oncologist Experience: 14+ YearsHospital Affiliation: CARE Hospitals
View Profile Book a Consultation
Image not available

Dr. Venkata Sampath V

MBBS, MD, DM
Consultant Medical Oncologist · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India15+ Years experience
Why consider this doctor?
  • 15+ years of experience in Medical Oncologist
  • Consultant Medical Oncologist, Apollo Hospital, Jubilee Hills, Hyderabad - Present
  • Consultant Oncologist, Yashoda Hospital, Secunderabad
Expertise & Procedures
  • Chemotherapy for solid tumors
  • Immunotherapy and immune checkpoint inhibitor therapy
  • Molecular targeted therapy based on biomarkers
  • Hormone therapy for breast and gynecologic cancers
  • Adjuvant and neoadjuvant chemotherapy
View all procedures →
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
View Profile Book a Consultation

Hospitals where these doctors practise

Medicover Hospital Hitec City🇮🇳 Hitec City, Hyderabad, India
Starting from$300

Medicover Hospital Hitec City

Est. 2011
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Targeted Therapy
4.3
95 reviews
250+
Beds
15+
Years Since Founded
Dr. Naidu N. Bethune
View Hospital Profile Enquire / Get Free Opinion
Apollo Hospitals, Jubilee Hills🇮🇳 Hyderabad, India
Starting from$300

Apollo Hospitals, Jubilee Hills

Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Targeted Therapy
4.1
44 reviews
550+
Beds
38+
Years Since Founded
Dr. Nikhil Suresh GhadyalpatilDr. Rekha BansalDr. Venkata Sampath V
View Hospital Profile Enquire / Get Free Opinion

Why consider treatment in India?

Many international patients consider India for multiple myeloma treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Targeted Therapy?

Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.

Who may be considered?

Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

3 approaches available for this procedure:

Biomarker/Genomic Testing & Drug Selection

Essential First Step

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

Comprehensive Investigations

Estimated cost: $300 - $1,500

Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests

Treatment / Procedure Estimate

Estimated cost in India: $300 - $2,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days

Usually Included in Hospital Package

  • Oncologist consultation
  • Tissue/blood sample processing
  • Genomic report interpretation
  • Tumor board review

Usually Not Included

  • International shipping of external samples
  • Repeat biopsy if sample inadequate
  • Second confirmatory pathology opinion

Recovery and follow-up

Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.

Risks

Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.

Alternatives

Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report
  • IHC/FISH biomarker results (HER2, ER/PR, etc.)
  • Next-generation sequencing (NGS) or mutation panel report
  • Recent CT/PET-CT/MRI imaging
  • Complete blood count and organ function tests
  • Prior treatment and chemotherapy history
  • Discharge summaries from previous hospitalizations
  • Current medication list

Patient information needed

  • Cancer type, stage, and site of primary tumor
  • Prior treatments including surgery, chemotherapy, radiation
  • Known genetic mutations or biomarker status if tested
  • Current performance status and comorbidities
  • Allergy history, especially to biologic drugs
  • Cardiac history if cardiotoxic drugs are anticipated
  • Insurance or budget considerations
  • Availability of a caregiver/companion during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Targeted Therapy in Hyderabad, India

What is Multiple Myeloma?
Multiple myeloma is a cancer in which abnormal plasma cells accumulate in the bone marrow, producing excess proteins (called M-proteins or paraproteins) that can damage organs and disrupt normal blood cell production. It is considered a haematological malignancy and, while not currently curable in most cases, it is treatable and can often be managed effectively for many years.
What are the symptoms and health risks of Multiple Myeloma?
Common symptoms include persistent bone pain (particularly in the back, ribs, or hips), unexplained fatigue, frequent infections, easy bruising or bleeding, and signs of kidney problems such as increased thirst or reduced urine output. Some people experience numbness or weakness in the limbs if the disease affects the spine, and elevated calcium levels can cause confusion, nausea, or constipation. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of multiple myeloma.
How is Multiple Myeloma diagnosed?
Diagnosis typically involves blood and urine tests to detect abnormal proteins (including serum protein electrophoresis, immunofixation, and free light chain assay), a full blood count, kidney and calcium level checks, and bone marrow biopsy to confirm the presence and proportion of malignant plasma cells. Imaging — such as whole-body low-dose CT, MRI, or PET-CT — is used to assess bone involvement and detect lesions. Disease severity is stratified using established staging systems such as the Revised International Staging System (R-ISS), which incorporates albumin, beta-2 microglobulin, LDH levels, and cytogenetic risk markers to guide prognosis and treatment decisions.
How is Multiple Myeloma treated?
Treatment is highly individualised and depends on factors including disease stage, cytogenetic risk profile, the patient's age, fitness, and organ function. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation (using the patient's own stem cells) is a standard approach that can deepen and prolong remission. Alongside or instead of transplant, treatment may include combinations of targeted therapies (such as proteasome inhibitors or IMiDs), immunotherapy (including monoclonal antibodies), and conventional chemotherapy, with the specific regimen determined by a qualified specialist based on individual assessment.
Can Multiple Myeloma be treated without a procedure?
For patients who are not eligible for stem cell transplantation — due to age, fitness level, or other health conditions — effective non-procedural management is available using combinations of oral or intravenous targeted agents, immunotherapy, and chemotherapy. Supportive care measures, including bisphosphonates to protect bone health, growth factors to address anaemia, and prophylactic antibiotics to reduce infection risk, form an important part of ongoing management for all patients regardless of transplant eligibility. Active monitoring (sometimes called 'watch and wait') may be appropriate for asymptomatic precursor states such as smouldering myeloma, but this decision must be made by a specialist following careful individual assessment.
When is Targeted Therapy considered for Multiple Myeloma?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Multiple Myeloma?
Multiple myeloma is typically evaluated and managed by a haematologist or medical oncologist with specific expertise in haematological malignancies. For patients being considered for stem cell transplantation, care is coordinated through a specialist in bone marrow transplantation, usually within a multidisciplinary team that may also include nephrologists, radiologists, and specialist nurses.
How do I choose a doctor for Multiple Myeloma?
When selecting a specialist or facility, it is worth asking about the centre's volume and experience specifically in treating multiple myeloma, whether they offer access to a full multidisciplinary team, availability of novel and clinical-trial therapies, and what structured follow-up and relapse monitoring looks like over the long term.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.
WhatsApp Us